We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Fluxion Biosciences announced that its BioFlux system was used in research on COVID-19 and its ability to lead to high levels of platelet coagulation and an increased risk of thrombosis.
Researchers who developed the dissolvable microcarrier for large-scale cell production and expansion say it offers higher yield and cost-effectiveness compared to traditional methods.
NeuroPointDX has launched what it says is the first objective blood test set up to help diagnose children with autism spectrum disorder earlier, which could help with quicker treatments for some.